LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	BMS345541	0.04	uM	LJP6	1	D06	72	hr	1657	5578	5505	1.0131	1.0188
BT-20	BMS345541	0.04	uM	LJP6	3	D06	72	hr	1657	5396	5505	0.9801	0.9715
BT-20	BI-2536	0.04	uM	LJP6	3	D18	72	hr	1657	1555	5505	0.2824	-0.0267
BT-20	Afatinib	0.04	uM	LJP6	1	G24	72	hr	1657	3973	5505	0.7216	0.6017
BT-20	BMS345541	0.04	uM	LJP6	2	D06	72	hr	1657	5332	5505	0.9685	0.9549
BT-20	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	1657	2747	5505	0.4989	0.2831
BT-20	BI-2536	0.04	uM	LJP6	1	D18	72	hr	1657	1284	5505	0.2332	-0.0971
BT-20	BI-2536	0.04	uM	LJP6	2	D18	72	hr	1657	1636	5505	0.2972	-0.0056
BT-20	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1657	5160	5505	0.9372	0.9102
BT-20	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1657	5258	5505	0.9550	0.9356
BT-20	Afatinib	0.04	uM	LJP6	3	G24	72	hr	1657	3836	5505	0.6967	0.5661
BT-20	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	1657	4978	5505	0.9042	0.8629
BT-20	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	1657	5065	5505	0.9200	0.8855
BT-20	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	1657	5098	5505	0.9260	0.8941
BT-20	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	1657	2746	5505	0.4988	0.2828
BT-20	Afatinib	0.04	uM	LJP6	2	G24	72	hr	1657	4132	5505	0.7505	0.6430
BT-20	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1657	2903	5505	0.5273	0.3236
BT-20	AZD7762	0.04	uM	LJP6	1	L06	72	hr	1657	5686	5505	1.0328	1.0469
BT-20	AZD7762	0.04	uM	LJP6	2	L06	72	hr	1657	6318	5505	1.1475	1.2111
BT-20	AZD7762	0.04	uM	LJP6	3	L06	72	hr	1657	5639	5505	1.0242	1.0347
BT-20	AZD8055	0.04	uM	LJP6	1	A12	72	hr	1657	2373	5505	0.4310	0.1859
BT-20	AZD8055	0.04	uM	LJP6	2	A12	72	hr	1657	2444	5505	0.4439	0.2043
BT-20	AZD8055	0.04	uM	LJP6	3	A12	72	hr	1657	2937	5505	0.5335	0.3325
BT-20	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1657	4928	5505	0.8951	0.8499
BT-20	SNS-032	0.04	uM	LJP6	1	H18	72	hr	1657	4703	5505	0.8542	0.7914

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)